The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
2018 05 18
Journal Article
Authors:
Samai, M.;
Seward, J.F.;
Goldstein, S.T.;
Mahon, B.E.;
Lisk, D.Radcliffe;
Widdowson, M.A.;
Jalloh, M.I.;
Schrag, S.J.;
Idriss, A.;
Carter, R.J.;
Dawson, P.;
Kargbo, S.A.S.;
Leigh, B.;
Bawoh, M.;
Legardy-Williams, J.;
Deen, G.;
Carr, W.;
Callis, A.;
Lindblad, R.;
Russell, J.B.W.;
Petrie, C.R.;
Fombah, A.E.;
Kargbo, B.;
McDonald, W.;
Jarrett, O.D.;
Walker, R.E.;
Gargiullo, P.;
Bash-Taqi, D.;
Gibson, L.;
Fofanah, A.Bakarr;
Schuchat, A.
Secondary:
J Infect Dis
Volume:
217
Pagination:
S6-S15
Issue:
suppl_1
PMID:
29788345
Keywords:
Adolescent; Adult; Aged; Drug-Related Side Effects and Adverse Reactions; Ebola Vaccines; Epidemics; Female; Hemorrhagic Fever, Ebola; Humans; Longitudinal Studies; Male; Middle Aged; Sierra Leone; Vaccines, Synthetic; Young Adult
Abstract:
Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].
